Stay updated on CAMMA 2 Clinical Trial - Cevostamab in BCMA-Exposed Myeloma

Sign up to get notified when there's something new on the CAMMA 2 Clinical Trial - Cevostamab in BCMA-Exposed Myeloma page.
Latest website image capture
Clouds background image

Latest updates to the CAMMA 2 Clinical Trial - Cevostamab in BCMA-Exposed Myeloma page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    A new revision tag (v3.6.3) was added to the history and the older tag (v3.6.0) was removed, reflecting an update to the page's revision history.
    Difference
    0.1%
    Check dated 2026-06-30T02:15:28.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    A new revision (v3.6.0) adds a note that the study is no longer looking for participants. The previous revision label (v3.5.5) is removed from the history.
    Difference
    0.3%
    Check dated 2026-06-15T19:46:37.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The page footer now displays revision v3.5.5 instead of v3.5.4, indicating a small update to the page's version.
    Difference
    0.1%
    Check dated 2026-06-08T17:15:13.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The study record history now includes a new revision entry, v3.5.4, as the latest update. This new revision supersedes the previous v3.5.3 entry and signals a minor log update in the record history.
    Difference
    0.1%
    Check dated 2026-05-18T06:54:00.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    New entries for Contacts/Locations and Study Status were added to the record history, with the latest version count updated to 37. An earlier version dated 2026-02-09 was removed from the history.
    Difference
    0.3%
    Check dated 2026-05-11T05:33:43.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    The page’s revision/version indicator has been updated from v3.5.2 to v3.5.3, indicating a software or interface update rather than a modification to the clinical trial record content.
    Difference
    0.1%
    Check dated 2026-04-25T18:12:34.000Z thumbnail image

Stay in the know with updates to CAMMA 2 Clinical Trial - Cevostamab in BCMA-Exposed Myeloma

Enter your email address, and we'll notify you when there's something new on the CAMMA 2 Clinical Trial - Cevostamab in BCMA-Exposed Myeloma page.